Kelman-Lazarov Inc’s GMO US Quality ETF QLTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16.4M Buy
382,092
+1,199
+0.3% +$50.9K 2.11% 17
2026
Q2
$15.9M Buy
380,893
+320
+0.1% +$12.8K 2.08% 18
2026
Q1
$13.8M Buy
380,573
+14,716
+4% +$564K 1.97% 18
2025
Q4
$14.1M Buy
365,857
+1,932
+0.5% +$72.7K 2.01% 18
2025
Q3
$13.2M Sell
363,925
-4,804
-1% -$168K 1.95% 18
2025
Q2
$12.6M Buy
368,729
+20,178
+6% +$640K 2.05% 17
2025
Q1
$10.9M Buy
348,551
+14,596
+4% +$476K 1.98% 17
2024
Q4
$10.7M Sell
333,955
-10,622
-3% -$345K 1.92% 16
2024
Q3
$11.2M Buy
344,577
+8,985
+3% +$283K 1.93% 17
2024
Q2
$10.4M Buy
335,592
+272,072
+428% +$8.11M 1.94% 16
2024
Q1
$1.89M Buy
+63,520
New +$1.8M 0.37% 33

Other funds holding QLTY

Kelman-Lazarov Inc's QLTY Position: Q3 2026 in Review

Kelman-Lazarov Inc increased its GMO US Quality ETF (QLTY) stake by 0.31% in Q3 2026, buying an estimated $50.9K and bringing the position to 382,092 shares worth $16.4M. The position accounts for 2.11% of the portfolio, ranked #17.

Kelman-Lazarov Inc first reported a position in QLTY in Q1 2024 and has held it in 11 quarters since. 172 funds tracked by Wall St. Rank hold QLTY as of Q3 2026.

  • Kelman-Lazarov Inc held 382,092 shares of GMO US Quality ETF worth $16.4M as of Q3 2026.
  • Kelman-Lazarov Inc bought 1,199 GMO US Quality ETF shares in Q3 2026, an estimated $50.9K.
  • GMO US Quality ETF made up 2.11% of Kelman-Lazarov Inc's portfolio in Q3 2026, its #17 holding.
  • Kelman-Lazarov Inc first reported a position in GMO US Quality ETF in Q1 2024 and has held it in 11 quarters since.
  • 172 funds tracked by Wall St. Rank held GMO US Quality ETF as of Q3 2026.

Based on Kelman-Lazarov Inc's 13F filing for Q3 2026, filed 9 Nov 2026.